Cited by 197Estrogen and related hormone effectsSmoking Behavior and CessationEffects and risks of endocrine disrupting chemicals

Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.

Open access
Barbieri, R L, Gochberg, J, Ryan, K J·1986·Journal of Clinical Investigation

Abstract

Epidemiologic studies suggest that women who smoke have lower endogenous estrogen than nonsmokers. To explore the possible link between cigarette smoking and decreased endogenous estrogens, we have examined the effects of constituents of tobacco on estrogen production in human choriocarcinoma cells and term placental microsomes. In choriocarcinoma cell cultures, nicotine, cotinine (a major metabolite of nicotine), and anabasine (a minor component of cigarette tobacco) all inhibited androstenedione conversion to estrogen in a dose-dependent fashion. Removal of nicotine, cotinine, and anabasine from the culture medium resulted in the complete reversal of the inhibition of aromatase. In the choriocarcinoma cell cultures, a supraphysiologic concentration of androstenedione (73 microM) in the culture medium blocked the inhibition of aromatase caused by nicotine, cotinine, and anabasine. In preparations of term placental microsomes, nicotine, cotinine, and anabasine inhibited the conversion of testosterone to estrogen. Kinetic analysis demonstrated the inhibition to be competitive with respect to the substrate. These findings suggest that some nicotinic alkaloids directly inhibit aromatase. This mechanism may explain, in part, the decreased estrogen observed in women who smoke.

Integrity signals

Registry

Crossref · 10.1172/jci112494

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 21 cited sources checked · 0 supported · 0 flagged

  • Findingown data

    In choriocarcinoma cell cultures, a supraphysiologic concentration of androstenedione (73 μM) blocks inhibition of aromatase caused by nicotine, cotinine, and anabasine.

    “In the chorio- carcinoma cell cultures, a supraphysiologic concentration of an- drostenedione (73 ,M) in the culture medium blocked the in- hibition of aromatase caused by nicotine, cotinine, and anabasine.”
    • Also stated in: § Effects ofnicotine, cotinine, and anabasine on estrogen accumulation in choriocarcinoma cell cultures · plain
      “when the culture medium contained 73 1tM androstenedione, 30 ,M nicotine produced no inhibition of estradiol accumulation (Fig. 4).”
    Quote in the paperSubstantial claim
  • Findingown data

    Aqueous extracts of cigarette smoke inhibit androstenedione conversion to estradiol in a dose-dependent manner in choriocarcinoma cell cultures.

    “Aqueous extracts ofsmoke inhibited androstenedione conversion to estradiol in a dose-dependent manner (Fig. I A).”
    Quote in the paperSubstantial claim
  • Findingown data

    Nicotine inhibits estradiol accumulation at the first timepoint examined, 1 h.

    “Examination of the timecourse of nicotine inhibition of estradiol accumulation demonstrated that nicotine inhibited es- tradiol accumulation at the first timepoint examined, 1 h (Fig. 3).”
    Quote in the paperNot a substantial claim
  • Findingown data

    At concentrations up to 150 μM, nicotine, cotinine, and anabasine do not alter cell number at the end of an 8-h incubation.

    “At con- centrations up to 150 ,uM, nicotine, cotinine, and anabasine did not alter cell number at the end of an 8-h incubation.”
    Quote in the paperSubstantial claim
  • Findingown data

    At concentrations in the range 0.3-2 mM, carbamylcholine, succinylcholine, hexamethonium, and decamethonium do not inhibit estradiol accumulation in choriocarcinoma cells.

    “In contrast, at concentrations in the range offoot_2 mM, carbamylcholine, succinylcholine, hexamethonium, and decamethonium did not inhibit estradiol accumulation (Table III).”
    Quote in the paperNot a substantial claim
  • May combine two claims. 9
  • Classified as probably not a substantial claim. 5
  • The quote only partly states this claim. 1
  • May combine two claims.

    Findingown data

    In all experiments, estradiol accumulation exceeds estrone accumulation, with an estradiol:estrone ratio of 6:1-10:1.

    “In all experiments the accumulation ofestradiol always exceeded the accumulation of estrone, and the ratio of estradiol to estrone was in the range of 6:1-10:1.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Addition of androstenedione to choriocarcinoma cultures results in appearance of both estradiol and estrone, but not testosterone or dihydrotestosterone.

    “Addition ofandrostenedione to the choriocarcinoma cultures resulted in the appearance ofboth estradiol and estrone, but not testosterone or dihydrotestosterone.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Addition of nicotine to choriocarcinoma cell cultures results in inhibition of both estradiol and estrone accumulation and a corresponding increase in unmetabolized androstenedione.

    “The addition of nicotine to the choriocarcinoma cell cultures resulted in the inhibition of both estradiol and es- trone accumulation and a corresponding increase in unmetab- olized androstenedione (Table I).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Partitioning experiments demonstrate that 95% of progesterone and estradiol are present in culture medium and <5% in explanted cells.

    “Using radioactive progesterone and estradiol, partitioning experiments demonstrated that 95% of these two steroids were present in the culture medium and <5% in the explanted cells.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Addition of 1 μCi [1,2-3H]progesterone or [6,7-3H]estradiol to 2×10^5 choriocarcinoma cells for 24 h results in conversion of <15% progesterone and <10% estradiol to other metabolites.

    “Ad- dition of 1 MCi of [1,2-3H]progesterone or [6,7-3H]estradiol to 2 X I05 choriocarcinoma cells for 24 h resulted in the conversion of < 15% of the progesterone and <10% of the estradiol to other metabolites as determined by high performance liquid chro- matography.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    At the doses used, aqueous extracts of cigarette smoke do not inhibit progesterone accumulation or cell number.

    “At the doses used in this study, aqueous extracts of cigarette smoke did not inhibit progesterone accu- mulation or the cell number present in the culture.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Addition of aminoglutethimide to preparations of placental microsomes elicits a type II cytochrome P450 binding spectrum.

    “The addition of aminoglutethimide to preparations ofplacental microsomes elicits a type II cytochrome P450 binding spectrum (20).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] 20. Meldrum, D. R., B. J. Davidson, I. V. Tataryn, and H. L. Judd. 1981. Changes in steroids with aging in postmenopausal women. Obstet. Gynecol. 57:624-628.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Naturally occurring plant flavones are potent inhibitors of aromatase.

    “Kellis and Vickery have reported that naturally occurring plant flavones are potent in- hibitors of aromatase (21).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [21] 21. Graves, P. E., and H. A. Salhanick. 1979. Stereoselective inhibition of aromatase by enantiomers of aminoglutethimide. Endocrinology. 105: 52-57. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Aminoglutethimide competitively inhibits aromatization of testosterone in placental microsomal preparations with an apparent Ki of 14 μM.

    “In placental microsomal preparations, aminoglutethimide competitively inhibits the aromatization of testosterone with an ap- parent Ki of 14 ,uM (20).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [20] 20. Meldrum, D. R., B. J. Davidson, I. V. Tataryn, and H. L. Judd. 1981. Changes in steroids with aging in postmenopausal women. Obstet. Gynecol. 57:624-628.
  • May combine two claims.

    Interpretationreasoning

    If the intrafollicular concentration of nicotine plus cotinine were 5 μM, the ratio of nicotine plus cotinine to androstenedione would be 2:1, which is too low to produce significant inhibition.

    “If the intrafollicular concentration of nicotine plus cotinine were 5 gM, the ratio of nicotine plus cotinine to androstenedione would be 2:1.This ratio is too low to produce significant inhi- bition.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Premisecitation

    The intrafollicular concentration of androstenedione is approximately 2.5 μM, about 500 times greater than the circulating concentration.

    “However, the intrafollicular concentration of androstenedione is -500 times greater, 2.5 ,M (30).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites [30] 30. Goodman, A. L., and G. D. Hodgen. 1983. The ovarian triad of the primate menstrual cycle. Recent Prog. Horm. Res. 39:1-73. source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Jensen et al. reported that in postmenopausal women, smoking may increase the metabolic clearance rate of estradiol.

    “Jensen et al. have recently reported that in postmenopausal women, smoking may increase the metabolic clearance rate of estradiol (31).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites [31] 31. McNatty, K. P., D. M. Smith, A. Makris, R. Osathanondh, and K. J. Ryan. 1979. The microenvironment of the human antral follicle: interrelationships among the steroid levels in antral fluid, the population of granulosa cells, and the status of the oocyte in vivo and in vitro. J. Clin. Endocrinol. Metab. 49:851-860. source
  • May combine two claims. The quote only partly states this claim.

    Interpretationreasoning

    If the corpus luteum is exposed to a nicotine plus cotinine concentration of 5 μM, the ratio of nicotine plus cotinine to androstenedione would be 1,000:1, which could produce significant inhibition of aromatase and a decrease in estrogen production.

    “If the corpus luteum is exposed to a nicotine plus cotinine concentration of 5 gM, then the ratio of nicotine plus cotinine to androstenedione would be 1,000:1.This high ratio could produce significant inhibition of the aro- matase system and a decrease in estrogen production.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S4 (based).

    Interpretationnone given

    The aromatase enzyme system in the corpus luteum is probably exposed to an androstenedione concentration similar to that in the circulation, 5 nM.

    “The aromatase en- zyme system in the cells comprising the corpus luteum is probably exposed to an androstenedione concentration similar to that in the circulation, 5 nM.”
    Quote in the paperNot a substantial claim
    • Rests on an assumption: In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is approximately 5 nM.
    • Rests on an assumption: In the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted and the follicular microenvironment is lost.
14 of 14
  • The authors state this as an assumption.

    The aromatase enzyme system in human granulosa cells is similar to placental aromatase.

    “If the granulosa cell and placental aromatase are similar, then the in vitro observation that nicotine and cotinine”
  • The paper relies on this without support.

    The concentrations of nicotine and cotinine in body fluids reflect their concentrations at the aromatase enzyme site in ovarian or placental tissues.

    “The nicotine and cotinine concentrations present in ovarian follicular fluid and in steroidogenic tissues of women who smoke have not been reported.However, the concentrations of nicotine and cotinine that have been re- ported to be present in the body fluids of women who smoke suggests that the in vitro findings reported here may have relevance in vivo.”
  • The paper relies on this without support.

    In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is approximately 5 nM.

    “In the follicular phase of the menstrual cycle, the circulating androstenedione concentration is -5 nM.”
  • The paper relies on this without support.

    In the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted and the follicular microenvironment is lost.

    “In contrast, in the luteal phase of the menstrual cycle, the basement membrane of the dominant follicle is disrupted, and the follicular microenvironment is lost.”
4 of 4

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Nicotine, cotinine, and anabasine inhibit the aromatase enzyme, also called estrogen synthase, in a reversible manner and suppress the production of estrogen.

    “First, nicotine, cotinine, and anabasine inhibit the aromatase enzyme, also called estrogen synthase, in a reversible manner and suppress the production of estrogen [56].”
  • Nicotine and cotinine suppress aromatase enzyme activity, contributing to a reduction in estrogen levels.

    “nicotine and cotinine suppress aromatase enzyme activity, contributing to a reduction in estrogen levels [54]”

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Barbieri, R. L., Gochberg, J., & Ryan, K. J.
Affiliations
Brigham and Women's Hospital (US)
Venue
Journal of Clinical Investigation
Published
1986-06-01
Volume
77
Issue
6
Pages
1727-1733
ISSN
0021-9738 (ISSN-L)
OpenAlex
W2115000106
Cited by
197
References
35
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 8 · 2021: 5 · 2020: 5 · 2019: 3 · 2018: 10 · 2017: 6 · 2016: 4 · 2015: 4 · 2014: 9 · 2013: 5 · 2012: 13
FWCI
3.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD18292)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
Keywords
nicotine, cotinine, anabasine, aromatase inhibition, tobacco smoke, estrogen synthesis, choriocarcinoma cells, placental microsomes, androstenedione, testosterone, competitive inhibition, endogenous estrogen
MeSH terms
Anabasine, Androstenedione, Carbachol, Cells, Cultured, Choriocarcinoma, Cotinine, Decamethonium Compounds, Dose-Response Relationship, Drug, Estradiol, Female, Hexamethonium Compounds, Humans, Kinetics, Microsomes, Nicotine, Piperidines, Placenta, Pregnancy, Pyrrolidinones, Smoking, Succinylcholine, Trophoblasts, Uterine Neoplasms, Aromatase Inhibitors, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-11-05.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-11-05.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review